Abbott Aiming to Produce 100M Covid Tests a Month: CEO

Abbott is expanding into bio wearables with its LINGO product line, aiming to monitor various health metrics. The company sees a convergence of health and technology, accelerated by the pandemic, and aims to lead in this space. Consumer attitudes towards healthcare have shifted, with increased demand for accessible health information. Abbott has faced challenges in COVID-19 testing due to high demand and supply chain issues but is working with governments to address these. The company believes that at-home diagnostic testing will become a lasting trend.

How does Abbott ensure the sensitivity of their tests for the Omicron variant?

What new consumer behavior regarding diagnostic testing is expected to emerge from the pandemic?

In what ways is Abbott planning to expand access to diagnostic testing?